RhoA/C inhibits proliferation by inducing the synthesis of GPRC5A

Area of Science:

• Cell Biology
• Molecular Oncology
• Cancer Research

Background:

• Rho GTPases are key regulators of cellular processes including migration, adhesion, and polarity.
• Dysregulation of Rho GTPases is frequently observed in various cancers.
• The orphan seven-transmembrane receptor G-protein-coupled receptor family C group 5 member A (GPRC5A) is implicated in cancer, with differential expression in breast and lung cancers.

Purpose of the Study:

• To investigate the functional role of GPRC5A in breast epithelial and breast cancer cells.
• To elucidate the relationship between Rho GTPases, GPRC5A, and cell proliferation.
• To understand the impact of GPRC5A on EGFR signaling pathways.

Main Methods:

• Cell culture of benign breast epithelial and breast cancer cell lines.
• Manipulation of RhoA/C activity and GPRC5A expression (including gene knockout).
• Assessment of cell proliferation, colony formation, and EGFR signaling.

Main Results:

• RhoA/C activation led to GPRC5A-dependent inhibition of proliferation and reduced colony formation in benign breast epithelial cells, mediated by EGFR signaling inhibition.
• Knockout of GPRC5A (RAI3) in breast cancer cells resulted in increased cell division, with Rho activation having no effect.
• Knockout of GPRC5A in benign breast epithelial cells decreased EGFR expression and diminished proliferation.

Conclusions:

• GPRC5A acts as a tumor suppressor in benign breast epithelial cells by inhibiting proliferation through EGFR signaling.
• Loss of GPRC5A promotes proliferation in breast cancer cells, suggesting a context-dependent role.
• Rho GTPases and GPRC5A interact to regulate cell proliferation, with implications for breast cancer progression.